Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus
about
Pharmacogenomics and personalized medicine: a review focused on their application in the Chinese populationAssociation study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patientsGlutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with CyclophosphamideAssociation of GSTT1 and GSTM1 polymorphisms with blood pressure: A Bayesian modeling of continuous data.Egyptian sweet marjoram leaves protect against genotoxicity, immunosuppression and other complications induced by cyclophosphamide in albino rats.Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.Gene polymorphisms in cyclophosphamide metabolism pathway,treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer.Genetic and epigenetic regulation of gene expression in fetal and adult human liversUnmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicineGenetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group.Glutathione S-transferases: an overview in cancer research.Pharmacogenetics: implications for therapy in rheumatic diseases.Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation.GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.Optimizing the use of existing therapies in lupus.Rare Cyclophosphamide-Induced Hemorrhagic Cystitis in a Chinese Population with Rheumatic DiseasesCon: Cyclophosphamide for the treatment of lupus nephritis.The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy.Genetic polymorphisms of glutathione S-transferases and cytochrome P450 enzymes as susceptibility factors to systemic lupus erythematosus in southern Brazilian patients.Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia.Generalized Multifactor Dimensionality Reduction (GMDR) Analysis of Drug-Metabolizing Enzyme-Encoding Gene Polymorphisms may Predict Treatment Outcomes in Indian Breast Cancer Patients.Epistatic interactions among CYP2C19*2, CYP3A4 and GSTP1 on the cyclophosphamide therapy in lupus nephritis patients.Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach.General adverse response to cyclophosphamide in Chinese patients with systemic autoimmune diseases in recent decade—a single-center retrospective study.Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer.Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
P2860
Q28083875-790CC049-BC33-49F3-8DCD-35508F56E40AQ28255901-E8102E22-B1A2-4C15-90E5-A544B840193DQ28550922-242CCEE4-9DF5-4CDD-B415-68A995DDE011Q30832426-759869C9-4EFE-48D1-84FA-B6662FC5267BQ33398772-752BBDBF-9BDC-41A2-AD5F-6B51E907B0E7Q33646358-02CE06B9-5920-4115-B4F7-052EEF84EC4FQ34682560-44221904-4142-48EB-8761-AC6E932E3709Q35302040-47DFA4CA-D9DA-4DD4-8759-17BB47BE2662Q36088877-D066E37B-196C-4AE4-B698-7697C2E29A79Q36802054-8E3058C0-8257-480C-A430-B46B7BEC171FQ36943992-CE4C4805-987A-4965-977F-F5B0D8A37583Q37676231-416B4A22-CBB4-44FA-B154-8DCD50185875Q37913989-F18672E3-4018-43A7-9270-4E64B682899FQ38063197-997CF32B-BCF6-4D18-AC12-6647A0752452Q38068541-E4E43545-9E20-4A87-84F0-52B6D36CAEE4Q38376375-E48F99D4-891E-4F38-AEEC-F714679BD036Q38425824-06E3374B-9715-460F-A7B3-662665F3B524Q38711151-DB4D0C10-4CDD-496E-87FF-F113211D0961Q38837080-F84B8229-B354-4562-AE4B-671687885D45Q38959130-434C5A61-F1DE-40B8-BFDA-555544B6BF6BQ43480092-D32D2AC2-9029-4112-8B6E-FFF1B04EA7A6Q46518382-C3B293D8-54DB-4265-845C-30D49DDBD57AQ48113822-3FD6AD02-C394-431B-8EB8-DADE0373C464Q49618000-4B667E4E-05FE-41A8-BB44-8E3852101860Q50868086-196BE097-A156-4B39-BA52-2CB8F787D683Q51125568-D6145CD6-31FD-4434-BFBE-C59AACF6A8DFQ51711572-957554BE-5A6D-4258-93D7-31C66DA188CDQ51744122-6E2AEB88-174A-4A47-927E-63BDB0B69496Q53146007-96A20487-FBC4-407C-8E55-65782AFB643A
P2860
Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Relationship of glutathione S- ...... h systemic lupus erythematosus
@ast
Relationship of glutathione S- ...... h systemic lupus erythematosus
@en
type
label
Relationship of glutathione S- ...... h systemic lupus erythematosus
@ast
Relationship of glutathione S- ...... h systemic lupus erythematosus
@en
prefLabel
Relationship of glutathione S- ...... h systemic lupus erythematosus
@ast
Relationship of glutathione S- ...... h systemic lupus erythematosus
@en
P2093
P2860
P1476
Relationship of glutathione S- ...... h systemic lupus erythematosus
@en
P2093
Liuqin Liang
Marjorie Romkes
Shilong Zhong
Shu-Feng Zhou
Xiuyan Yang
P2860
P304
P356
10.1111/J.1365-2125.2006.02690.X
P407
P577
2006-10-01T00:00:00Z